The competitive environment in 2026 is no longer dominated solely by pharmaceutical companies. The Delirium Market share is currently contested by a diverse mix of medical device giants (like Medtronic and GE HealthCare) and specialized neuro-tech startups. The "Competitive Edge" in 2026 belongs to companies that offer "Integrated Solutions"—combining a screening device with a management...